Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$111.15 - $128.97 $694,798 - $806,191
-6,251 Reduced 27.01%
16,890 $1.92 Million
Q2 2024

Aug 14, 2024

BUY
$123.8 - $132.96 $210,583 - $226,164
1,701 Added 7.93%
23,141 $2.86 Million
Q1 2024

May 15, 2024

BUY
$113.24 - $131.95 $2.43 Million - $2.83 Million
21,440 New
21,440 $2.83 Million
Q2 2023

Aug 14, 2023

BUY
$108.61 - $118.38 $1.05 Million - $1.14 Million
9,630 Added 280.68%
13,061 $1.51 Million
Q1 2023

May 15, 2023

BUY
$102.94 - $114.86 $353,187 - $394,084
3,431 New
3,431 $365,000
Q2 2022

Aug 15, 2022

BUY
$83.49 - $94.64 $1.04 Million - $1.18 Million
12,468 Added 475.7%
15,089 $1.38 Million
Q1 2022

May 16, 2022

BUY
$73.51 - $82.4 $192,669 - $215,970
2,621 New
2,621 $215,000
Q2 2021

Aug 16, 2021

SELL
$70.31 - $77.77 $281,240 - $311,080
-4,000 Closed
0 $0
Q1 2021

May 17, 2021

BUY
$68.86 - $81.11 $275,440 - $324,440
4,000 New
4,000 $308,000
Q3 2020

Nov 16, 2020

SELL
$73.18 - $82.95 $199,342 - $225,955
-2,724 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$70.42 - $80.13 $191,824 - $218,274
2,724 New
2,724 $211,000
Q2 2019

Aug 14, 2019

SELL
$69.84 - $81.59 $189,056 - $220,864
-2,707 Closed
0 $0
Q1 2019

May 15, 2019

BUY
$69.58 - $79.36 $188,353 - $214,827
2,707 New
2,707 $225,000
Q2 2018

Aug 14, 2018

SELL
$50.83 - $59.72 $1.12 Million - $1.32 Million
-22,036 Closed
0 $0
Q1 2018

May 15, 2018

BUY
$50.96 - $59.23 $139,171 - $161,757
2,731 Added 14.15%
22,036 $1.2 Million
Q4 2017

Feb 14, 2018

BUY
$51.62 - $61.64 $996,524 - $1.19 Million
19,305 New
19,305 $1.09 Million
Q3 2017

Nov 14, 2017

SELL
$58.67 - $63.13 $528,030 - $568,170
-9,000 Closed
0 $0
Q2 2017

Aug 29, 2017

BUY
N/A
9,000
9,000 $577,000

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $240B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Caxton Associates LP Portfolio

Follow Caxton Associates LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Caxton Associates LP, based on Form 13F filings with the SEC.

News

Stay updated on Caxton Associates LP with notifications on news.